IPSC - Century Therapeutics GAAP EPS of -$0.55 revenue of $0.1M
2023-11-09 13:26:01 ET
More on Century Therapeutics
- Century Therapeutics appoints Brent Pfeiffenberger as Chief Executive Officer
- JP Morgan cuts Century Therapeutics to neutral, cites lengthy data timeline
- Seeking Alpha’s Quant Rating on Century Therapeutics
- Historical earnings data for Century Therapeutics
- Financial information for Century Therapeutics
For further details see:
Century Therapeutics GAAP EPS of -$0.55, revenue of $0.1M